Please login to the form below

Not currently logged in
Email:
Password:

Konstantin Linnik to head IP strategy at Idea Pharma

Former senior corporate counsel at Pfizer joins clinical stage strategy consultancy as general counsel and principal IP strategist

Konstantin Linnik - Idea PharmaIdea Pharma has appointed former senior corporate counsel at Pfizer Konstantin Linnik as its general counsel and principal intellectual property (IP) strategist.

Idea, which specialises in advising a company's strategy at the phase II stage of development, said Linnink will lead IP inputs into whole product design, giving insight into the potential opportunities for early phase assets and advising on how to improve developmental products.

The appointment is also expected to expand Idea's portfolio of clients to medium-sized pharma companies, and also give the company a base in Boston, US.

Linnik, who will join from Boston law firm Nutter McClennen and Fish LLP, said Idea's focus on distinct elements such as IP during early phase development influenced his decision to join the company.

He said: “A small change in product concept, that produces a better medicine, one with even six months more protection, can make billions of dollars difference over the lifecycle.”

Mike Rea, CEO of Idea, said: “The fantastic thing about Konstantin is that he gets it - that the role of invention isn't over when someone comes up with a pathway and a molecule.”

20th December 2011

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Hanson Zandi

Hanson Zandi is a Creative and Digital Healthcare Agency. We combine 30 years’ experience with the enthusiasm of a start-up...

Latest intelligence

Spotlight interview: 15 minutes on insights and market research in pharma
Neil Rees, Head of Research, OPEN Health Patient & Brand Communication takes 15 minutes to answer some key questions on insights and market research in pharma...
WHITE PAPER: The increasing importance of clinical trial marketing advertising in patient recruitment
Learn why advertising is more important than ever in clinical studies...
The 'winner takes all' pricing game
Tendering has long been common in healthcare for medical devices and diagnostics; the Gulf Cooperation Council and the Jamaica Commodity Trading Company have been using pharmaceutical tendering since the 1970s....

Infographics